Author:
Li Zhixia,Zhang Yuan,Quan Xiaochi,Yang Zhirong,Zeng Xiantao,Ji Linong,Sun Feng,Zhan Siyan
Funder
National Natural Science Foundation of China
Research Fund for the Doctoral Program of Higher Education
Publisher
Public Library of Science (PLoS)
Reference129 articles.
1. Treatment of type 2 diabetes with glucagon-like peptide-1 receptor agonists;KB Hansen;Int J Clin Pract,2009
2. Insulin Glargine: a review 8 years after its introduction;S Goykhman;Expert opinion on pharmacotherapy,2009
3. Effects of glucagon-like peptide 1 on counterregulatory hormone responses, cognitive functions, and insulin secretion during hyperinsulinemic, stepped hypoglycemic clamp experiments in healthy volunteers;MA Nauck;The Journal of clinical endocrinology and metabolism,2002
4. Both GLP-1 and GIP are insulinotropic at basal and postprandial glucose levels and contribute nearly equally to the incretin effect of a meal in healthy subjects;T Vilsboll;Regulatory peptides,2003
5. Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and beta-cell function in type 2 diabetes: a parallel-group study;M Zander;Lancet,2002
Cited by
21 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献